The rule change, which HHS’ Substance Abuse and Mental Health Services Administration proposed Dec. 13, would allow clinicians to prescribe buprenorphine via telehealth visits and permit patients to receive take-home doses of methadone.
SAMSA issued a waiver allowing these flexibilities during the pandemic. Prior to these reforms, many patients had to travel to an addiction clinic daily to receive a single dose of methadone.
At present, these waivers will expire when the national public health emergency ends Jan. 11, 2023.
HHS is accepting public comments on the proposal through Feb. 14.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
